Cytokinetics | CYTK - Umlaufvermögen

Aktienkurs
65.01
Täglich Wechseln
0.42 0.65%
Monatlich
2.17%
Jährlich
68.20%
Q2 Prognose
63.24




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Arca Biopharma USD 343.86M 11.31M 2025-12
Bayer EUR 32.91B 30M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Brainstorm Cell Therapeutics USD 307K 201K 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Capricor Therapeutics USD 322.94M 221.99M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Geron USD 520.27M 2.07M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 3.09B 2025-12